Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxybutynin Gel in Urge Incontinence
NCT00909181Phase 3Completed
- Sponsor
- Antares Pharma, Inc.
- Start
- Mar 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxybutynin in overactive bladder (OAB), sponsored by Antares Pharma, Inc.. Started Mar 2009; status: completed.
02
Drugs
oxybutynin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00909181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00909181.